Research Compound

CJC + Ipamorelin

Overview

CJC + Ipamorelin is a two-component research formulation containing CJC without DAC and Ipamorelin. The components are peptides studied in experimental research involving growth-hormone secretagogue and growth-hormone-releasing signaling pathways.

Composition

CJC (No DAC) - 5 mg

Ipamorelin - 5 mg

Presentation

Lyophilized Powder

Storage

Store refrigerated. Protect from light.

Published Research

Research Literature

Scientific ReviewFrontiers in Endocrinology · 2026

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

View on PubMed →

References are provided for scientific and bibliographic context. Inclusion does not imply that the cited publication evaluated this specific Ascend product or formulation.

Research Use

Product information is provided for research and analytical reference purposes.